Protagonist Therapeutics (PTGX) Other Working Capital Changes (2017 - 2026)
Protagonist Therapeutics (PTGX) reported Other Working Capital Changes of -$547000.0 for Q1 2026, up 90.05% on a YoY basis from -$287823.1 in Q1 2025, and up 92.65% sequentially from -$7.4 million in Q4 2025.
Protagonist Therapeutics (PTGX) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Protagonist Therapeutics (PTGX) has 10 years of Other Working Capital Changes data on file, last reported at -$547000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 90.05% year-over-year to -$547000.0; the trailing twelve-month figure through Mar 2026 stood at -$16.1 million (up 19.56% YoY), and the FY2025 full-year result was -$21.0 million, down 168.76% from the prior year.
- Other Working Capital Changes rose to -$547000.0 in Q1 2026, from -$7.4 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.0 million in Q2 2024 to a low of -$3.3 million in Q4 2022.
- A 5-year average of $149352.9 and a median of $365000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes soared 23120.1% in 2024 and slumped 112.2% in 2025, its largest moves.
- Tracing PTGX's Other Working Capital Changes over 5 years: stood at -$768000.0 in 2022, then jumped by 125.26% to $194000.0 in 2023, then slumped by 3006.19% to -$5.6 million in 2024, then plunged by 31.93% to -$7.4 million in 2025, then soared by 92.65% to -$547000.0 in 2026.
- Business Quant data shows PTGX's Other Working Capital Changes at -$547000.0 in Q1 2026, -$7.4 million in Q4 2025, and -$3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Protagonist Therapeutics | 8.88 Bn | 8.88 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -547,000.00 |
| Mar 31, 2026 | -547,000.00 |
| Mar 31, 2026 | -547,000.00 |
| Dec 31, 2025 | -7.44 Mn |
| Dec 31, 2025 | -7.44 Mn |
| Dec 31, 2025 | -7.44 Mn |
| Sep 30, 2025 | -3.08 Mn |
| Sep 30, 2025 | -3.08 Mn |
| Sep 30, 2025 | -3.08 Mn |
| Jun 30, 2025 | -5.01 Mn |
| Jun 30, 2025 | -5.01 Mn |
| Jun 30, 2025 | -5.01 Mn |
| Mar 31, 2025 | -5.50 Mn |
| Mar 31, 2025 | -5.50 Mn |
| Mar 31, 2025 | -5.50 Mn |
| Dec 31, 2024 | -5.64 Mn |
| Dec 31, 2024 | -5.64 Mn |
| Dec 31, 2024 | -5.64 Mn |
| Sep 30, 2024 | -4.68 Mn |
| Sep 30, 2024 | -4.68 Mn |